AAAAAA
Results: 1-25/51
Authors:
Bashore, TM
Bates, ER
Kern, MJ
Berger, PB
Laskey, WK
Clark, DA
O'Laughlin, MP
Cusma, JT
Oesterle, S
Dehmer, GJ
Popma, JJ
Citation: Tm. Bashore et al., American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on cardiac catheterization laboratory standards: Summary of a report of the American College of Cardiology task force on clinical expert consensus documents, CATHET C IN, 53(2), 2001, pp. 281-286
Authors:
Berger, PB
Citation: Pb. Berger, Science misapplied: mandatory addiction screening and treatment for welfare recipients in Ontario, CAN MED A J, 165(4), 2001, pp. 443-444
Authors:
Berger, PB
Citation: Pb. Berger, D is for drug addiction - and disability, CAN MED A J, 164(11), 2001, pp. 1565-1566
Authors:
Batchelor, WB
Mahaffey, KW
Berger, PB
Deutsch, E
Meier, S
Hasselblad, V
Fry, ET
Teirstein, PS
Ross, AM
Binanay, CA
Zidar, JP
Citation: Wb. Batchelor et al., A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: The ATLAST trial, J AM COL C, 38(6), 2001, pp. 1608-1613
Authors:
Berger, PB
Velianou, JL
Vlachos, HA
Feit, F
Jacobs, AK
Faxon, DP
Attubato, M
Keller, N
Stadius, ML
Weiner, BH
Williams, DO
Detre, KM
Citation: Pb. Berger et al., Survival following coronary angioplasty versus coronary artery bypass surgery in anatomic subsets in which coronary artery bypass surgery improves survival compared with medical therapy - Results from the Bypass Angioplasty Revascularization Investigation (BARI), J AM COL C, 38(5), 2001, pp. 1440-1449
Authors:
Bashore, TM
Bates, ER
Berger, PB
Clark, DA
Cusma, JT
Dehmer, GJ
Kern, MJ
Laskey, WK
O'Laughlin, MP
Oesterle, S
Popma, JJ
O'Rourke, RA
Abrams, J
Bates, ER
Brodie, BR
Douglas, PS
Gregoratos, G
Hlatky, MA
Hochman, JS
Kaul, S
Tracy, CM
Waters, DD
Winters, WL
Citation: Tm. Bashore et al., American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document on Cardiac Catheterization Laboratory standards - A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents, J AM COL C, 37(8), 2001, pp. 2170-2214
Authors:
Berger, PB
Gersh, BJ
Citation: Pb. Berger et Bj. Gersh, Ventricular function after primary angioplasty for acute myocardial infarction: correlates and caveats, EUR HEART J, 22(9), 2001, pp. 726-728
Authors:
Cote, AV
Berger, PB
Holmes, DR
Scott, CG
Bell, MR
Citation: Av. Cote et al., Hemorrhagic and vascular complications after percutaneous coronary intervention with adjunctive abciximab, MAYO CLIN P, 76(9), 2001, pp. 890-896
Authors:
Singh, M
Nuttall, GA
Ballman, KV
Mullany, CJ
Berger, PB
Holmes, DR
Bell, MR
Citation: M. Singh et al., Effect of abciximab on the outcome of emergency coronary artery bypass grafting after failed percutaneous coronary intervention, MAYO CLIN P, 76(8), 2001, pp. 784-788
Authors:
Holmes, DR
Berger, PB
Citation: Dr. Holmes et Pb. Berger, Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, andinfarctlets - What's behind this new lexicon and what does it add?, CIRCULATION, 104(6), 2001, pp. 627-629
Authors:
Steinhubl, SR
Talley, JD
Braden, GA
Tcheng, JE
Casterella, PJ
Moliterno, DJ
Navetta, FI
Berger, PB
Popma, JJ
Dangas, G
Gallo, R
Sane, DC
Saucedo, JF
Jia, G
Lincoff, AM
Theroux, P
Holmes, DR
Teirstein, PS
Kereiakes, DJ
Citation: Sr. Steinhubl et al., Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention - Results of the GOLD (AU-Assessing Ultegra) multicenter study, CIRCULATION, 103(21), 2001, pp. 2572-2578
Authors:
Berger, PB
Schaff, HV
Alderman, EL
Nadel, A
Citation: Pb. Berger et al., Graft patency rate and clinical outcome after coronary artery bypass surgery - Response, CIRCULATION, 103(2), 2001, pp. E10-E10
Authors:
Singh, M
Berger, PB
Ting, HH
Rihal, CS
Wilson, SH
Lennon, RJ
Reeder, GS
Bresnahan, JF
Holmes, DR
Citation: M. Singh et al., Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (The Mayo Clinic experience), AM J CARD, 88(10), 2001, pp. 1091-1096
Authors:
Berger, PB
Bellot, V
Bell, MR
Horlocker, TT
Rihal, CS
Hallett, JW
Dalzell, C
Melby, SJ
Charnoff, NE
Holmes, DR
Citation: Pb. Berger et al., An immediate invasive strategy for the treatment of acute myocardial infarction early after noncardiac surgery, AM J CARD, 87(9), 2001, pp. 1100-1102
Authors:
Ting, HH
Tahirkheli, NK
Berger, PB
McCarthy, JT
Timimi, FK
Mathew, V
Rihal, CS
Hasdai, D
Holmes, DR
Citation: Hh. Ting et al., Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure, AM J CARD, 87(5), 2001, pp. 630-633
Authors:
Cantor, WJ
Kaplan, AL
Velianou, JL
Sketch, MH
Barsness, GW
Berger, PB
Ohman, EM
Citation: Wj. Cantor et al., Effectiveness and safety of Abciximab after failed thrombolytic therapy, AM J CARD, 87(4), 2001, pp. 439
Authors:
Berger, PB
Dzavik, V
Penn, IM
Catellier, D
Buller, CE
Citation: Pb. Berger et al., Does ticlopidine reduce reocclusion and other adverse events after successful balloon angioplasty of occluded coronary arteries? Results from the Total Occlusion Study of Canada (TOSCA), AM HEART J, 142(5), 2001, pp. 776-781
Authors:
Al Suwaidi, J
Velianou, JL
Berger, PB
Mathew, V
Garratt, KN
Reeder, GS
Grill, DE
Holmes, DR
Citation: J. Al Suwaidi et al., Primary percutaneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting, AM HEART J, 142(3), 2001, pp. 452-459
Authors:
Dzavik, V
Carere, RG
Mancini, GBJ
Cohen, EA
Catellier, D
Anderson, TE
Barbeau, G
Lazzam, C
Title, LM
Berger, PB
Labinaz, M
Teo, KK
Buller, CE
Citation: V. Dzavik et al., Predictors of improvement in left ventricular function after percutaneous revascularization of occluded coronary arteries: A report from the Total Occlusion Study of Canada (TOSCA), AM HEART J, 142(2), 2001, pp. 301-308
Authors:
Wilson, SH
Bell, MR
Rihal, CS
Bailey, KR
Holmes, DR
Berger, PB
Citation: Sh. Wilson et al., Infarct artery reocclusion after primary angioplasty, stent placement, andthrombolytic therapy for acute myocardial infarction, AM HEART J, 141(5), 2001, pp. 704-710
Authors:
Rathore, SS
Gersh, BJ
Berger, PB
Weinfurt, KP
Oetgen, WJ
Schulman, KA
Solomon, AJ
Citation: Ss. Rathore et al., Acute myocardial infarction complicated by heart block in the elderly: Prevalence and outcomes, AM HEART J, 141(1), 2001, pp. 47-54
Authors:
Berger, PB
Citation: Pb. Berger, Oral antiplatelet agents - Aspirin, ticlopidine, clopidogrel, cilostazol, and the oral glycoprotein IIb/IIIa inhibitors, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 453-497
Authors:
Kastrati, A
Koch, W
Berger, PB
Mehilli, J
Stephenson, K
Neumann, FJ
von Beckerath, N
Bottiger, C
Duff, GW
Schomig, A
Citation: A. Kastrati et al., Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting, J AM COL C, 36(7), 2000, pp. 2168-2173
Authors:
Berger, PB
Bell, MR
Holmes, DR
Citation: Pb. Berger et al., Risk of neutropenia with clopidogrel - Reply, J AM COL C, 36(4), 2000, pp. 1436-1437
Authors:
Singh, M
Rihal, CS
Berger, PB
Bell, MR
Grill, DE
Garratt, KN
Barseness, GW
Holmes, DR
Citation: M. Singh et al., Improving outcome over time of percutaneous coronary interventions in unstable angina, J AM COL C, 36(3), 2000, pp. 674-678